Myozyme and tachycardia 
Myozyme and tachycardia Patient Reports February 13, 2012
Myozyme Side Effects Report #5325824-8
Myozyme side effect was reported by a Physician from GERMANY on Apr 26, 2007. Female patient, 58 years of age, weighting 159.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, dyspnoea, erythema, oxygen saturation decreased, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5102881-5
Myozyme side effect was reported by a Physician from KOREA, REPUBLIC OF on Aug 24, 2006. Female patient, 29 years of age, weighting 74.96 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: face oedema, flushing, gastric ulcer, infusion related reaction, pneumonia bacterial, pruritus, rash maculo-papular, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with RANITIDINE, TAZOBACTAM, ISEPAMICIN. Patient recovered.
Myozyme Side Effects Report #5713823-3
Myozyme side effect was reported by a Health Professional from UNITED STATES on Apr 09, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: ear infection
, erythema, infusion related reaction, lung disorder, oxygen saturation decreased, rash , tachycardia. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5725882-2
Myozyme side effect was reported by a Physician from UNITED STATES on Apr 18, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: ear infection
, erythema, glycogen storage disease type ii, infusion related reaction, lung disorder, oxygen saturation decreased, rash , tachycardia. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5748505-5
Myozyme side effect was reported by a Physician from UNITED STATES on May 05, 2008. Male patient, child 2 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chronic respiratory disease, ear infection
, erythema, infusion related reaction, pneumonia aspiration, rash , tachycardia. Myozyme dosage: 300 MG, Q2W, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Myozyme Side Effects Report #5081199-3
Myozyme side effect was reported by a Physician from UNITED STATES on July 27, 2006. Male patient, 14 years of age, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure increased, bronchospasm, chest discomfort, chills, cyanosis, flushing, infusion related reaction, tachycardia, tachypnoea. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, BENADRYL, TYLENOL, STEROID. Patient recovered.
Myozyme Side Effects Report #5229469-X
Myozyme side effect was reported by a Physician from UNITED STATES on Jan 17, 2007. Male patient, weighting 15.21 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, cardiac arrest
, infection , pyrexia, respiratory distress, tachycardia, wheezing. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN, POTASSIUM CHLORIDE, FAMOTIDINE, DIGOXIN, PROPRANOLOL, FUROSEMIDE, HYDROCHLOROTHIAZIDE. Patient recovered.Myozyme Side Effects Report #5285757-2
Myozyme side effect was reported by a Health Professional from UNITED STATES on Nov 22, 2006. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: body temperature increased, chills, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA. Patient recovered.
Myozyme Side Effects Report #5285766-3
Myozyme side effect was reported by a Physician from UNITED STATES on Sept 29, 2006. Male patient, weighting 18.74 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chills, hyperhidrosis, pallor, tachycardia, tremor. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, LASIX, SIMETHICONE, ZANTAC, BENADRYL, TYLENOL. Patient recovered.
Myozyme Side Effects Report #5285767-5
Myozyme side effect was reported by a Physician from UNITED STATES on Sept 29, 2006. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chills, cyanosis, dyskinesia, hyperhidrosis, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, TYLENOL, BENADRYL. Patient recovered.
Myozyme Side Effects Report #5268621-4
Myozyme side effect was reported by a Physician from BRAZIL on Feb 28, 2007. Female patient, weighting 16.31 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bradycardia, brain oedema, cardiogenic shock, cardiomyopathy
, cyanosis, disease progression, pyrexia, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with CARVEDILOL, CAPTOPRIL. Patient died on 02/13/2007.Myozyme Side Effects Report #5302484-3
Myozyme side effect was reported by a Physician from GERMANY on Mar 29, 2007. Female patient, weighting 159.8 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchospasm, chest discomfort, erythema, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS IV. Patient recovered.
Myozyme Side Effects Report #5093635-7
Myozyme side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Male patient, weighting 16.53 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: blood immunoglobulin e increased, blood immunoglobulin g increased, blood pressure decreased, infusion related reaction, tachycardia, urticaria. Myozyme dosage: 20 MG/KG Q2WKS IV. During the same period patient was treated with ALPHA, CLARINEX, DIPHENHYDRAMINE, RANITIDINE, XOPENEX, PULMICORT, REGLAN. Patient recovered.
Myozyme Side Effects Report #5205587-7
Myozyme side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Male patient was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chills, cyanosis, dyskinesia, hyperhidrosis, tachycardia. Myozyme dosage: 20 MG/KG Q2WKS; IV. During the same period patient was treated with ALPHA, TYLENOL, BENADRYL. Patient recovered.
Myozyme Side Effects Report #5205599-3
Myozyme side effect was reported by a Physician from UNITED STATES on Aug 31, 2006. Male patient, weighting 18.74 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: chills, hyperhidrosis, pallor, tachycardia, tremor. Myozyme dosage: 20 MG/KG Q2WKS; IV. During the same period patient was treated with ALPHA, LASIX, SIMETHICONE, ZANTAC, BENADRYL, TYLENOL. Patient recovered.
Myozyme Side Effects Report #5622249-2
Myozyme side effect was reported by a Physician from GERMANY on Jan 23, 2008. Female patient, weighting 13.01 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac failure, pneumonia
, pyelonephritis, tachycardia. Myozyme dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient died on 01/06/2008.Myozyme Side Effects Report #5657647-4
Myozyme side effect was reported by a Physician from GERMANY on Feb 19, 2008. Female patient, weighting 13.01 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardiac arrest
, cardiac failure, cardiomegaly, oedema, pneumonia , procedural complication, pyelonephritis, tachycardia, ventricular hypertrophy. Myozyme dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient was hospitalized. Patient died on 01/06/2008.Myozyme Side Effects Report #5753890-4
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on May 16, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W; INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5930343-1
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Oct 17, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #5930832-X
Myozyme side effect was reported by a Physician from KUWAIT on Oct 16, 2008. Male patient, weighting 12.13 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, coma, hypotension, pneumonia
, pyrexia, respiratory distress, tachycardia, wheezing. Myozyme dosage: 100 MG, Q2W, INTRAVENOUS. During the same period patient was treated with VENTOLIN, LASIX, ALDACTONE, CAPTOPRIL, DOPAMINE. Patient was hospitalized and became disabled. Patient died on 07/18/2008.Myozyme Side Effects Report #5945822-0
Myozyme side effect was reported by a Physician from CROATIA (local name: Hrvatska) on Oct 24, 2008. Female patient, weighting 18.52 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: bronchial obstruction, dyspnoea, hypersensitivity, oxygen saturation decreased, tachycardia, tachypnoea. Myozyme dosage: 200 MG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Myozyme Side Effects Report #6111696-0
Myozyme side effect was reported by a Pharmacist from UNITED STATES on Mar 10, 2009. Male patient, weighting 38.80 lb, was diagnosed with glycogen storage disease type ii and was treated with Myozyme. After drug was administered, patient experienced the following side effects: anxiety
, flushing, hypotension, hypoxia, infusion related reaction, tachycardia. Myozyme dosage: 350 MG EVERY 2 WEEKS IV DRIP. Patient was hospitalized. Patient recovered.